BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2003
View Archived Issues
IDM exercises option to license cancer epitopes from Epimmune
Read More
New inverse agonist at alpha2-adrenoceptors enhances cognition in rats
Read More
Use of dopamine D3 agonists in sexual dysfunction
Read More
ARYx describes novel delivery systems for analgesics
Read More
Novel Wyeth compounds that increase HDL cholesterol
Read More
Shire BioChem designs series for Flavivirus infections
Read More
Inhibitors of beta-secretase claimed for Rx of Alzheimer's disease and related disorders
Read More
Agents for herpesvirus infections reported in recent patent
Read More
First European approval for a drug to reduce risk of suicidal behavior
Read More
Novocell encapsulated islet cell implants successful in diabetic primates
Read More
Multikine may enhance success of radiation and chemotherapy in H&N cancer
Read More
Updated GOLD guidelines for COPD treatment include first-line tiotropium
Read More
CG-5601, a potential alternative to thalidomide for ocular inflammation
Read More
Evidence of antitumor efficacy found for PDX in NSCLC
Read More
FDA requests additional data for Follistim
Read More
DOR BioPharma executes worldwide license agreement for rights to ricin vaccine technology
Read More
Repaglinide vs. nateglinide in combination with metformin for type 2 diabetes
Read More
FDA advisory committee hands down positive opinion for Crestor
Read More
Pralnacasan phase IIb clinical trial begins enrollment
Read More
Preliminary findings reveal troponin I suppresses genes associated with angiogenesis
Read More
Potential residual effects described for rivastigmine in Alzheimer's disease after discontinuation
Read More
FibroGen awarded grant to develop cancer therapies
Read More
Myriad Genetics collaborates with the Mayo Clinic to develop novel Alzheimer's drugs
Read More
Clinical efficacy of tetrathiomolybdate in advanced kidney cancer
Read More